Dáil Éireann Debate, Thursday - 28 January 2021
267. Deputy Ruairí Ó Murchú asked the Minister for Health when the HSE executive management team will consider the recommendations and decide on the approval for reimbursement of the drug dupilumab; and if he will make a statement on the matter. [4802/21]
Amharc ar fhreagraThe HSE has statutory responsibility for decisions on pricing and reimbursement of medicines under the community drug schemes, in accordance with the provisions of the Health (Pricing and Supply of Medical Goods) Act 2013; therefore, the matter has been referred to the HSE for reply to the Deputy.
